Welcome to the international HTA database

Showing [23806 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2011	HAYES, Inc.	Robotically assisted stereotactic radiosurgery for intracranial indications
2011	NIHR Horizon Scanning Centre (NIHR HSC)	Ipilimumab (Yervoy) for prostate cancer – second line
2011	Institute for Clinical Effectiveness and Health Policy (IECS)	[Dabigatran for the prevention of ischemic stroke in patients with acute or chronic atrial fibrillation]
2011	Institut national d'excellence en sante et en services sociaux (INESSS)	[Indications for positron emission tomography (pet): a brief update]
2011	Institute for Clinical Effectiveness and Health Policy (IECS)	[Vagus nerve stimulation for refractory epilepsy]
2011	HAYES, Inc.	Robotically assisted stereotactic radiosurgery for thoracic and abdominal indications
2011	NIHR Horizon Scanning Centre (NIHR HSC)	Masitinib with gemcitabine for advanced or metastatic pancreatic cancer
2011	Institute of Health Economics (IHE)	Fecal transplantation for the treatment of clostridium difficile-associated disease or ulcerative colitis
2011	Institute for Clinical Effectiveness and Health Policy (IECS)	[Usefulness of urea breath test for helicobacter pylori detection]
2011	Institute for Clinical Effectiveness and Health Policy (IECS)	[Sacral nerve stimulation for the treatment of voiding dysfunction]
2011	HAYES, Inc.	Robotically assisted stereotactic radiosurgery (SRS) for spinal and extracranial head and neck indications
2011	NIHR Horizon Scanning Centre (NIHR HSC)	Paclitaxel (Paclical) for epithelial ovarian cancer, fallopian tube cancer or peritoneal cancer – second or third line
2011	Institute for Clinical Effectiveness and Health Policy (IECS)	[Pascal laser use in the treatment of retinal pathology]
2011	Medical Services Advisory Committee (MSAC)	Use of artificial disc replacement in patients with cervical degenerative disc disease
2011	Institute for Clinical Evaluative Sciences (ICES)	Geographic access to primary care and hospital services for rural and northern communities: Report to the Ontario Ministry of Health and Long-Term Care.
2011	Institute for Clinical Effectiveness and Health Policy (IECS)	[Therapeutic hypothermia in patients who underwent cardiac arrest resuscitation]
2011	NIHR Horizon Scanning Centre (NIHR HSC)	Dalcetrapib for the prevention of cardiovascular events
2011	Medical Services Advisory Committee (MSAC)	Assessment of application for joint injections
2011	Institute for Clinical Effectiveness and Health Policy (IECS)	[Botulinum toxin use in adults and children with urinary tract function disorders]
2011	HAYES, Inc.	HLA-B*27 testing for ankylosing spondylitis
2011	NIHR Horizon Scanning Centre (NIHR HSC)	Edoxaban tosylate for prevention of stroke and systemic embolic events in non-valvular atrial fibrillation
2011	Institute for Clinical Effectiveness and Health Policy (IECS)	[Carotid echo doppler for plaque area measurement in cardiovascular risk stratification]
2011	Medical Services Advisory Committee (MSAC)	Review of interim funded service: Hyperbaric Oxygen Therapy (HBOT) for the treatment of chronic non-diabetic wounds and non-neurological soft tissue radiation injuries
2011	Institute for Clinical Evaluative Sciences (ICES)	Economic evaluation of percutaneous coronary intervention in stable coronary artery disease: studies in utilities, costs and decision modelling
2011	Institute for Clinical Effectiveness and Health Policy (IECS)	[Pipeline embolization device]
2011	HAYES, Inc.	KIT and PDGFRA testing for diagnosis of gastrointestinal stromal tumors (GISTs)
2011	NIHR Horizon Scanning Centre (NIHR HSC)	HHLivC (Human Heterologous Liver Cells) for urea cycle disorders
2011	Institute for Clinical Effectiveness and Health Policy (IECS)	[Usefulness of COL4A1 gene sequencing]
2011	German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI)	[Benefit assessment of HPV testing in primary screening for cervical cancer]
2011	Basque Office for Health Technology Assessment (OSTEBA)	[Analysis and development of preventive activities in primary care. Review of the preferential offer and its support software (PAP)]
2011	HAYES, Inc.	KIT and PDGFRA testing for prognosis of gastrointestinal stromal tumors (GISTs)
2011	NIHR Horizon Scanning Centre (NIHR HSC)	ThromboLUX™ for determining platelet quality
2011	Agenzia nazionale per i servizi sanitari regionali (Agenas)	HIFU for the treatment of prostate cancer
2011	Institute for Clinical Effectiveness and Health Policy (IECS)	[Usefulness of a specific intra-necrotic interventional technique for the diabetic Foot]
2011	Medical Services Advisory Committee (MSAC)	Review of MBS Items for specific ophthalmology services under the MBS Quality Framework Stage 1
2011	Committee for New Health Technology Assessment (CNHTA)	[Sialendoscopy]
2011	Institute for Clinical Effectiveness and Health Policy (IECS)	[Usefulness of video EEG for the assessment of patients with refractory epilepsy]
2011	HAYES, Inc.	Leri-weill dyschondrosteosis
2011	NIHR Horizon Scanning Centre (NIHR HSC)	Rituximab (MabThera) for anti-neutrophil cytoplasmic antibody (ANCA) associated vasculitis
2011	Institute for Clinical Effectiveness and Health Policy (IECS)	[Pro-BNP peptide in the diagnosis and prognosis of heart failure]
2011	University of York	Supporting women with postnatal depression through psychological therapies
2011	The Swedish Council on Health Technology Assessment (SBU)	[Bleeding peptic ulcer]
2011	Committee for New Health Technology Assessment (CNHTA)	[Debridement using hydrosurgery system]
2011	Institute for Clinical Effectiveness and Health Policy (IECS)	[Endoscopic mucosectomy for the treatment of sessile polyps ]
2011	HAYES, Inc.	Topoisomerase II alpha (TOP2A) testing to predict response to treatment of breast cancer
2011	NIHR Horizon Scanning Centre (NIHR HSC)	Odanacatib for post-menopausal osteoporosis – first or second line
2011	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Abiraterone acetate (ZytigaTM) as 2nd-line therapy for the treatment of metastatic castration-resident prostate cancer after docetaxel therapy
2011	Institute for Clinical Effectiveness and Health Policy (IECS)	[Treatment of benign prostatic hypertrophy - Barreiro method]
2011	University of York	Evidence briefing on specialist nurses in acute hospital settings
2011	Committee for New Health Technology Assessment (CNHTA)	[Camera manipulating robot assisted endoscopic surgery]
2011	Institute for Clinical Effectiveness and Health Policy (IECS)	[Effectiveness of eculizumab in the treatment of paroxysmal nocturnal hemoglobinuria]
2011	HAYES, Inc.	Canaloplasty (iTrack 250A canaloplasty microcatheter; iScience Interventional Inc.) for primary open-angle glaucoma
2011	NIHR Horizon Scanning Centre (NIHR HSC)	Tocilizumab (RoACTEMRA) for early rheumatoid arthritis not treated with methotrexate – first line
2011	University of York	Evidence briefing on nurse endoscopy
2011	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Clinical practice guideline on borderline personality disorders]
2011	Institute for Clinical Effectiveness and Health Policy (IECS)	[Toric intraocular lenses]
2011	HAYES, Inc.	CellSearch circulating tumor cell (CTC) kit (Veridex LLC) for monitoring metastatic breast cancer
2011	NIHR Horizon Scanning Centre (NIHR HSC)	Dimethyl fumarate for relapsing-remitting multiple sclerosis
2011	Institute for Clinical Effectiveness and Health Policy (IECS)	[Intensity modulated radiation therapy for three dimensional breast cancer]
2011	University of York	Evidence briefing on integrated care pathways in mental health settings
2011	Committee for New Health Technology Assessment (CNHTA)	[Transanal radiofrequency treatment of fecal incontinence]
2011	Institute for Clinical Effectiveness and Health Policy (IECS)	[Electrical stimulation devices to treat delayed unions and pseudarthrosis]
2011	HAYES, Inc.	C-leg prosthesis (Otto Bock HealthCare LP)
2011	NIHR Horizon Scanning Centre (NIHR HSC)	Lacosamide (Vimpat) for epilepsy – first and second line
2011	Institute for Clinical Effectiveness and Health Policy (IECS)	[Botulinum toxin for the treatment of headache]
2011	The Swedish Council on Health Technology Assessment (SBU)	[Benign Prostatic Obstruction (BPO)]
2011	Committee for New Health Technology Assessment (CNHTA)	[autologous platelet rich plasma application]
2011	Institute for Clinical Effectiveness and Health Policy (IECS)	[Usefulness of prometheus in severe liver failure]
2011	HAYES, Inc.	CMI magnetocardiograph model 2409 (CardioMag Imaging Inc.) for diagnosis of acute chest pain
2011	Canadian Agency for Drugs and Technologies in Health (CADTH)	Aerosol-generating procedures and risk of transmission of acute respiratory infections: a systematic review
2011	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Everolimus for the treatment of unresectable or metastatic neuroendocrine tumours of pancreatic origin
2011	Institute for Clinical Effectiveness and Health Policy (IECS)	[Virtual hysterosalpingograghy to evaluate the uterus and tubes patency]
2011	Committee for New Health Technology Assessment (CNHTA)	[HBV entecavir resistance mutation [PCR-RFMP]]
2011	Institute for Clinical Effectiveness and Health Policy (IECS)	[Arrhythmia ablation by EnSite NavX electroanatomical mapping]
2011	HAYES, Inc.	Cooled radiofrequency denervation of the sacroiliac joint (pain management sInergy system, Baylis Medical Co. Inc.) for treatment of chronic low back pain
2011	Canadian Agency for Drugs and Technologies in Health (CADTH)	Guidelines and recommendations for ADHD in children and adolescents
2011	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Rituximab (Rituxan®/MabThera®) for the first- and second-line treatment of chronic lymphocytic leukaemia
2011	Agenzia nazionale per i servizi sanitari regionali (Agenas)	Systematic review of the methodological instruments used in Health Technology Assessment
2011	Institute for Clinical Effectiveness and Health Policy (IECS)	[Drug-eluting balloon for the treatment of coronary stenosis]
2011	HAYES, Inc.	EsophyX system with srosaFuse fastener (EndoGastric Solutions) for endoluminal repair for gastroesophageal reflux disease (GERD)
2011	Canadian Agency for Drugs and Technologies in Health (CADTH)	Optimal pre-operative testing and assessment for adult patients undergoing elective surgical procedures: a review of the clinical evidence and guidelines
2011	Agenzia nazionale per i servizi sanitari regionali (Agenas)	Systematic review of economic evaluation on the use of PET-CT for cancer staging
2011	Committee for New Health Technology Assessment (CNHTA)	[BRAF Gene, Mutation(Peptide Nucleic Acid Mediated Real-time PCR Clamping Method)]
2011	Institute for Clinical Effectiveness and Health Policy (IECS)	[Robotic gynecological surgery]
2011	HAYES, Inc.	Exhaled breath condensate pH testing for asthma management
2011	Canadian Agency for Drugs and Technologies in Health (CADTH)	Transcatheter aortic valve implantation for aortic stenosis: a review of the clinical effectiveness and guidelines
2011	Institute for Clinical Effectiveness and Health Policy (IECS)	[Real time intraoperative magnetic resonance imaging monitoring]
2011	HAYES, Inc.	Ex-PRESS glaucoma filtration device (Alcon Inc.) for treatment of primary open-angle glaucoma
2011	Canadian Agency for Drugs and Technologies in Health (CADTH)	Multidisciplinary treatment programs for patients with non-malignant pain: a review of the clinical evidence, cost-effectiveness, and guidelines
2011	Institute for Clinical Effectiveness and Health Policy (IECS)	[Percutaneous acrylic vertebroplasty for the treatment of vertebral fractures]
2011	HAYES, Inc.	eXtreme lateral interbody fusion (XLIF; NuVasive Inc.) for treatment of chronic low back pain
2011	Canadian Agency for Drugs and Technologies in Health (CADTH)	Nabilone for chronic pain management: a review of clinical effectiveness, safety, and guidelines
2011	Committee for New Health Technology Assessment (CNHTA)	[Urine neural thread protein]
2011	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	[Impact from HTA-research for the Austrian health care system. Part 2: Results of the empirical survey]
2011	Institute for Clinical Effectiveness and Health Policy (IECS)	[Dalfampridine (ampyra) in multiple sclerosis patients]
2011	HAYES, Inc.	Implantable interStim neurostimulator (Medtronic Inc.) for sacral neuromodulation in treatment of fecal incontinence in adults
2011	Canadian Agency for Drugs and Technologies in Health (CADTH)	Endovascular thermal ablation technologies for treatment of varicose veins: a review of clinical effectiveness, safety, cost-effectiveness, and guidelines
2011	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	[Training therapy in physical medicine – Systematic Review]
2011	Agenzia nazionale per i servizi sanitari regionali (Agenas)	[Consultation on the spread of tele-assistance for the management of the patient in post-stroke rehabilitation]
2011	Committee for New Health Technology Assessment (CNHTA)	[I-125 permanent implant for prostate cancer]